{"id":481401,"title":"Qualifying notice amendment for Lumakras (274523) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:35:34.762000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-amendment-lumakras-274523.html?wbdisable=true","snippet":"Qualifying notice amendment for Lumakras (274523) Pharmaceutical Drugs Directorate Holland Cross, Tower \"B\" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa ON K1A 0K9 Dossier identifier (ID): HC6-024-e230960 Control number: 274523 Amgen Canada Inc. c/o [name of…","rawSnapshotUrl":"/api/snapshots/raw/481401","browseUrl":"https://replay.healtharchive.ca/job-6/20260106163534/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-amendment-lumakras-274523.html?wbdisable=true#ha_snapshot=481401","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}